Pericardial effusion and lung cancer: a retrospective analysis.

Avinash Aujayeb, Hannah Tufayl,Karl Jackson,Hussun-Ara Shah

Clinical medicine (London, England)（2022）

引用 0|浏览0

暂无评分

摘要

Malignant pericardial involvement is present in 20% at post-mortems of cancer patients with up to 50% having a pericardial effusion (PErF). Common causes are lung and breast cancer. Survival of lung cancer and PErF is <5 months. Positive cytology and tamponade are adverse prognostic signs. We sought

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要